Unfortunately, the lack of species cross-reactivity of A-552 to mouse IL-36α or IL-36γ precluded assessing the effects of this inhibitor in preclinical mouse models of psoriasiform dermatitis induced by injection of IL-23 or the TLR7 agonist IMQ. Here, IL36G is linked to Psoriasiform dermatitis.